Re-examining equity in urology

Abstract

INTRODUCTION

Gender equity in urology has received considerable focus over the last decade, with collective efforts directed toward greater female presence, authorship, and leadership. Measurable advancement has been attained, but new data suggest the more complex reality: persistent inequalities coexist with growing perceptions of reverse bias among male urologists, thus adding new dimensions to workforce satisfaction, retention, and well-being. We aimed to synthesize peer-reviewed evidence on gender equity in urology, map progress and remaining gaps, and explore emerging perceptions of reverse bias to guide balanced, data-driven policies.

METHODS

This scoping review followed the PRISMA-ScR framework and included English-language, peer-reviewed studies published between January 2009 and September 2025. Studies examining gender equity, representation, leadership, compensation, authorship, patient preferences, or clinician well-being within urology were included. A comprehensive search of PubMed, Embase, Scopus, and Web of Science was conducted, supplemented by hand-searching urology-specific journals and reference lists. Two reviewers independently screened studies and extracted data using a standardized form capturing study design, population, outcomes, and key findings. Results were synthesized narratively and organized into six domains.

RESULTS

A total of 44 studies were included, spanning six domains: 1) workforce representation; 2) academic promotion and leadership; 3) authorship and scholarly visibility; 4) compensation and industry engagement; 5) patient preferences and clinical outcomes; and 6) perceptions of reverse bias and clinician well-being. Although female representation and authorship have increased, imbalances remain in leadership, pay, and editorial influence. Notably, tentatively emerging evidence indicates that male urologists sense diminished transparency in promotion and hiring, adding to dissatisfaction, burnout, and attrition.

CONCLUSIONS

Attainment of sustainable equity in urology will demand a measurement-first strategy based on transparent, data-driven policies. Professional societies need to spear-head the construction of equity dashboards to track workforce composition, promotion timelines, compensation trends, and authorship representation. Prospective, multi-institutional studies are needed to assess both ongoing inequities and dynamic understandings of fairness so that equity initiatives fortify, not fissure, the urology workforce.

INTRODUCTION

The pursuit of gender equity in urology constitutes a vital and timely challenge for the medical community. Historically, women have been significantly underrepresented in this surgical specialty, which has conventionally been dominated by men.¹ Over the past decade, however, there has been a concerted global effort to enhance female participation, leadership representation, and academic advancement in urology. These initiatives are underpinned not only by principles of fairness but also by increasing evidence that diverse healthcare teams foster innovation, improve patient outcomes, and cultivate more inclusive professional environments.¹ This shift mirrors broader trends across medicine and aligns with frameworks, such as the SAGER guidelines, AAMC DEI principles, and the recommendations of the Canadian Urological Association (CUA), all of which emphasize the necessity of addressing systemic barriers that affect women and other underrepresented groups in academic medicine.

Persistent inequities in urology

Despite noteworthy advancement in equity endeavors, there remains wide variance at the senior levels of academic and clinical leadership. Women are still inadequately represented in positions, including department chairs, society presidents, and senior authors, and their scholarly work receives lower citation rates when compared to their male counterparts. ² Such differences are also intensified by delayed promotion timelines, pay inequities, and limited access to mentorship and opportunities for sponsorship, all of which are infrastructures critical for long-term advancement.

Female authorship, although better, remains lower than male, especially in senior authorship and editorial leadership positions.³ Likewise, industry participation gaps also exist, with women substantially less likely to be considered for high-value consulting or honoraria payment.⁴ Together, these results highlight the fact that despite improvements, equity is best attained through systemic data-driven reforms as opposed to piecemeal adjustments.

Emerging evidence on reverse bias and workforce well-being

In addition to conventional metrics, emerging evidence underscores a novel and insufficiently examined aspect: the perceptions of male urologists regarding reverse bias within developing institutional frameworks. Preliminary studies indicate that certain male clinicians perceive a diminished transparency in promotion, hiring, and industry engagement opportunities, thereby raising concerns about equity and merit-based advancement.⁵

Such perceptions, not yet fully understood, have significant bearing on the workforce. New data link these issues with increased dissatisfaction, burnout, and risk of attrition in certain settings.^6,7 With burnout rates reaching 50–68% among urologists as a group, institutional trust needs to be addressed, and transparent evidence-based policies need to be assured in the interest of maintaining workforce cohesion and stability.

Patient preferences and downstream impacts

Patient preferences add additional layers of complexity to the equity landscape. While many patients stress clinical ability, numerous studies reveal strong preferences for urologists of the same gender, particularly during genital exams/procedures.⁸ Such preferences shape the distribution of cases and procedural opportunities, as well as referral behavior. For example, female urologists are more likely to treat women (54% vs. 23% by their male counterparts),⁹ an effect potentially inadvertently limiting the opportunities for procedural exposure for certain high-complexity subspecialties and potentially altering academic paths. Notably, current evidence finds no meaningful distinctions in clinical results by surgeon sex, noting that workforce diversity increases patient access and convenience without sacrificing the quality of care.¹⁰

Rationale for this review

Against the background of highly fractured current literature, there is a need for comprehensive synthesis. Earlier reviews have primarily focused on female underrepresentation with insufficient inclusion of the full breadth of workforce dynamics, including nascent views on reverse bias, clinician well-being, and patient-centered factors that influence career progression.

To the best of our knowledge, this represents the inaugural scoping review that systematically maps the literature regarding gender equity in urology, while concurrently incorporating evidence pertaining to unintended consequences and perceived fairness among male clinicians.

This scoping review aims to:

1. Map the peer-reviewed literature on gender equity in urology (2009–2025).

2. Summarize workforce, academic, authorship, compensation, and clinical outcomes across multiple domains.

3. Identify gaps — particularly regarding perceptions of reverse bias and clinician well-being — to inform future research.

4. Propose measurement-first, evidence-based strategies to guide balanced, transparent, and sustainable policy development.

By consolidating the available evidence, this review provides a nuanced, data-driven framework for advancing gender equity in urology, balancing representation with merit-based recognition, while ensuring that all clinicians feel valued, supported, and equitably treated.

METHODS

Framework and reporting

This scoping review was conducted following the methodologic framework established by Arksey and O’Malley and refined by Levac et al.^11,12 The review process adhered to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR) guidelines to ensure transparent, reproducible, and comprehensive reporting.

Eligibility criteria

Study eligibility was defined using the Population-Concept-Context (PCC) framework recommended by the Joanna Briggs Institute:

• Population: Studies involving urologists, residents, fellows, trainees, patients, or other healthcare professionals relevant to urology practice.

• Concept: We included studies exploring gender-related differences or equity outcomes across multiple domains, including:

  • ○ Workforce representation and pipeline trends

  • ○ Academic promotion and leadership

  • ○ Authorship and scholarly visibility

  • ○ Compensation and industry engagement

  • ○ Patient preferences and clinical outcomes

  • ○ Emerging perceptions of reverse bias and clinician well-being

• Context: Studies conducted within academic medicine, clinical practice, residency training, or professional societies, without restrictions on geographic location.

Inclusion criteria:

• English-language

• Peer-reviewed

• Published between January 1, 2009, and September 3, 2025

• Original research, bibliometric analyses, registry studies, narrative or systematic reviews, or meta-analyses

Exclusion criteria:

• Editorials, opinion pieces, or commentaries without supporting data

• Case reports unrelated to broader gender outcomes

• Non-English-language publications

Information sources

A comprehensive multi-database search was performed to identify relevant studies:

• Databases searched:

  • ○ PubMed / MEDLINE

  • ○ Embase

  • ○ Scopus

• Web of Science

• Hand-searching and supplemental strategies:

  • ○ Urology-specific journals: Journal of Urology, Urology Practice, BJU International, Canadian Urological Association Journal (CUAJ), and European Urology Open Science

  • ○ Backward citation chaining from reference lists of included studies

  • ○ Manual review of American Urological Association (AUA), European Association of Urology (EAU), and Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU) abstracts to identify recently presented but fully published studies

Search strategy

A structured search strategy was developed in collaboration with an experienced medical librarian and adapted for each database. The PubMed search string is provided as an example: (urology*[Title/Abstract] OR “Urology”[Mesh]) AND ((gender OR sex OR women OR female OR men) AND (equity OR equality OR diversity OR inclusion OR representation OR leadership OR promotion OR authorship OR citation OR compensation OR salary OR “industry payments” OR burnout OR mentorship OR “patient preference” OR concordance OR outcomes OR mortality OR “reverse bias” OR discrimination)) AND (“2009/01/01”[Date - Publication]: “2025/09/03”[Date - Publication]).

Study selection

All search results were imported into Rayyan QCRI for deduplication, title/abstract screening, and full-text review.

• Screening process:

  • ○ Two reviewers independently assessed titles and abstracts.

  • ○ Full-texts of potentially eligible studies were reviewed using predefined inclusion/exclusion criteria.

  • ○ Discrepancies were resolved through discussion and, when necessary, adjudication by a third senior reviewer.

The final study selection process is summarized in the PRISMA-ScR flow diagram (Figure 1).

Figure 1.

PRISMA-ScR flow diagram for the identification, screening, eligibility, and inclusion of studies examining gender equity and perceptions of bias in urology (January 2009 to September 2025). Records were identified from four databases: PubMed (n=612), Embase (n=488), Scopus (n=530), and Web of Science (n=462), totaling 2092 database records, plus 91 additional records from hand-searching and citation chaining.⁴⁸

Data charting

A standardized data extraction form was developed and piloted on a subset of studies before full application. The following key variables were collected for each included study:

• PMID/DOI: Unique article identifier

• Authors/year/journal: Bibliographic information

• Country and setting: Geographic and practice context

• Study design/dataset: Study methodology and data source

• Population: Urologists, trainees, patients, etc.

• Outcome(s): Equity-related variables, e.g., promotion, compensation, authorship

• Key findings: 1–2-sentence summary

• Limitations: As reported by study authors

Synthesis of results

Results were synthesized using three complementary approaches:

1. Tabulation: Detailed study characteristics presented across six domains (Supplementary Tables 1–6; available at cuaj.ca)

2. Descriptive statistics: Counts, ranges, and proportions were calculated where applicable (e.g., proportion of women in leadership roles)

3. Narrative synthesis: Findings were summarized qualitatively, with emphasis on:

   • ○ Where evidence converges (e.g., persistent leadership gaps)

   • ○ Where findings diverge (e.g., differing perceptions of promotion fairness)

   • ○ Emerging areas of inquiry (e.g., male perceptions of reverse bias and clinician well-being)

RESULTS

A total of 44 peer-reviewed studies published from 2009–2025 were included (final count reflected in PRISMA-ScR flow diagram). Findings are organized across six domains: 1) workforce and pipeline trends; 2) academic promotion and leadership; 3) authorship and scholarly impact; 4) compensation and industry engagement; 5) patient preferences and clinical outcomes; and 6) exploring perceptions of reverse bias and clinician well-being.

Detailed study characteristics are summarized in Supplementary Tables 1–6 (available at cuaj.ca).

Workforce and pipeline trends

Female representation urology has risen appreciably but is not yet at parity. In the U.S., practicing female urologists doubled (+104%) between 2007 and 2019, yet growth among residents slowed to +28% during the same period, suggesting pipeline stagnation.¹³ Internationally, Sierra et al reported that female trainees now comprise >50% of urology residents in some European nations, but women remain underrepresented among consultants and senior academic faculty.¹⁴

Projections for the future reveal long-standing imbalances. Jackson et al calculated that, at the current pace, women would represent only an estimated 38% of practicing urologists in the U.S. by 2062.¹⁵ Similarly, Nam et al forecast continuing shortages on a per-capita basis, suggesting diversity targets need to harmonize with larger capacity needs.¹⁶

Workplace climate disparities persist, particularly for women. Morin et al found that female urologists report higher rates of negative treatment (66% vs. 3%), gender bias (39% vs. 1%), and work-family conflict (95% vs. 75%) than men, despite similar weekly hours (approximately 44 vs. 46);¹⁷ however, new data suggest that male urologists also face systemic stressors, including rising workloads and declining institutional support, contributing to shared dissatisfaction and burnout.

Despite expanded female representation, equity is still years away. Both sexes encounter increasing stress on the job, supporting the need for equity remedies that deal with systemic stress on the whole labor force.

Academic promotion and leadership

Academic progression disparities persist. Breyer et al found that female faculty took an extra 1.2 years relative to male faculty for promotion from the level of Assistant to Associate Professor (7.3 years vs. 6.1 years, p<0.01), and men are three times more likely to receive early promotion (four years or less).¹⁸

Leadership representation remains strikingly low. Cancian et al found that women hold approximately 10% of leadership roles across major urology organizations and only 1–2% of department chair positions.¹⁹ In subspecialty boards, Dullea et al observed modest improvement (11% to 14% from 2014–2020), although some boards still reported zero female members.²⁰ Editorial leadership mirrors these gaps, with women occupying just 11.9% of editorial board seats in major journals.²¹

Emerging evidence underscores the perspectives of males regarding the fairness of advancement. Surveys conducted by Martin et al revealed a divergence in perceptions of equity between male and female urologists, with some male respondents articulating concerns that institutional policies might deprioritize merit-based promotion. ⁵ These findings suggest an increasing necessity for transparent and objective benchmarks for advancement in order to alleviate perceived inequities.

Female underrepresentation persists, as does editorial power, but an equally pressing issue is the need to ensure advancing equity initiatives that are transparent and to gain trust among the workforce.

Authorship and scholarly impact

Female authorship has grown over the years, albeit with persisting gaps in senior roles. Prunty et al investigated 59 375 articles (2002–2020), with female first authorship almost doubling (15% to 29%), whereas senior authorship showed less of an improvement (10% 19%).²² Mayer et al demonstrated that men have higher h-index scores (15 vs. 7) but with comparable yearly productivity (m-quotient), suggesting the aggregate differences relate to shorter career length rather than diminished scholarly potential among women.²³

Crucially, editorial diversity influences authorship patterns. Prunty et al demonstrated that journals with higher female editorial representation have significantly greater female authorship rates.³ Yet, Burg et al found that women still occupy only 14.6% of editorial board positions globally, reinforcing structural bottlenecks in research visibility and influence.²⁴

Female scholarly contributions are rising, but editorial and senior authorship inequities remain entrenched, warranting structural reforms to ensure equitable recognition.

Compensation and industry engagement

Gender-based pay gaps persist across all career stages. Spencer et al reported that female urologists earn $70 000–80 000 less annually than men, even after adjusting for hours, practice setting, and fellowship training. ²⁵ North et al similarly found men were more likely to earn >$350 000 annually (57% vs. 40%) despite comparable workloads.²⁶

Such inequities tend to appear in the beginning of training. Cone et al found that female residents reported lower expectations for compensation and felt less capable in contract negotiations, suggesting the possibility of long-term impact on pay.²⁷

Industry engagement reflects these disparities. Wang et al reported that female urologists are approximately 40% less likely to receive top-tier consulting or honoraria payments, particularly within academic positions.⁴ Interestingly, Reed et al discovered that high-value payments are concentrated among a small subset of high-volume surgeons, the majority of whom are male. This emphasizes potential perceptions of inequity if institutional initiatives alter access to these roles without transparency.²⁸

Inequities in compensation persist and are multifactorial. With evolving policies, equitable distribution of opportunities across industry, grant sponsorships for research, and leadership development are imperative to sustaining workforce cohesion.

Patient preferences and clinical outcomes

Patient preference has considerable influence on the patterns of referral, as well as clinical exposure. Tamalunas et al found that 65% of patients prefer a specific gender when they select a urologist, especially for intimate procedures.⁸ In similar findings, Wynn et al and Razdan et al found strong gender-concordant preference, especially among women.^29,30

Passarelli et al found female urologists treat 54% female patients, in contrast to 23% for men, indicating the pattern of patient preference rather than physician preference.⁹ Saka et al also indicated similar complication and mortality between surgeon genders, which highlights diversity increases the comfort for the patient without lowering the quality of care.¹⁰

While patient preferences affect referral patterns and procedural exposure, clinical outcomes remain comparable across genders, reinforcing the importance of balanced workforce representation.

Emerging evidence: Perceptions of reverse bias & clinician well-being

A novel theme identified in this review is emerging perceptions of reverse bias among male urologists, a domain that remains underexplored but increasingly relevant.

Burnout affects all clinicians; Narang et al conducted a cross-sectional survey of practicing U.S. urologists (2017–2019) using the Maslach Burnout Inventory, defining burnout as emotional exhaustion ≥27 or depersonalization ≥10. They reported that 49.1% (85/173) of respondents met criteria for burnout, with longer work hours associated with burnout and personality traits such as resilience and optimism appearing protective.⁶ Koo et al analyzed the 2019 AUA Census of U.S. urology residents (n=415) using the same inventory and found that 47% met criteria for professional burnout, with the highest prevalence in PGY-2 trainees (65%). In the same cohort, 17% reported overall career-choice regret and 9% specialty-choice regret, and women more often reported difficulty attending personal health appointments than men (70% vs. 53%).⁷

Perceptions of equity vary; Martin et al conducted a multi-society subspecialty survey (n=430) using the Culture Conducive to Women’s Academic Success (CCWAS) instrument. Male urologists rated practice culture toward women significantly more favorably than their female counterparts (median CCWAS 203.5, interquartile range [IQR] 184.25–225.0 vs. 162.5, IQR 130.75–188.0, p<0.0001), revealing consistent gender differences in perceived institutional equity.⁵

Cheng et al surveyed 476 participants (377 practicing urologists and 99 residents/fellows) using an abbreviated Maslach instrument and reported that 49.6% met burnout criteria. High emotional exhaustion was found in 40.7%, high depersonalization in 30.7%, and low personal accomplishment in 18.3%. Exercise and socializing were protective, while stress-eating and alcohol use correlated with higher burnout.³¹

Evidence on perceived reverse bias remains preliminary and primarily survey-based, requiring further longitudinal and cross-institutional evaluation.

While quantitative evidence is limited, these findings collectively indicate substantial burnout across the urology workforce and statistically significant gender differences in perceived equity, highlighting the need for measurement-first, transparent policies that advance diversity without alienating any subgroup.

DISCUSSION

This scoping review highlights results from 44 peer-reviewed articles from 2009–2025 to clarify trends in gender equity in urology. While significant progress has been achieved, particularly in the areas of trainee recruitment, authorship representation, and patient-centered care, enduring disparities persist in leadership, compensation, and editorial influence. This review further identifies a novel and underexplored theme: the increasing perceptions among male urologists regarding reverse bias and inequity, which underscores the necessity for equity frameworks that are balanced, data-driven, and inclusive of all clinicians.

Workforce representation and well-being

Female representation in urology has continued to increase steadily, with a two-fold increase among practicing urologists in the U.S. from 2007–2019.¹³ Globally, similar trends are seen;¹⁴ however, the increase has reached a plateau, and by 2062, an estimate suggests women will make up only 38% of the U.S. workforce.¹⁵

Growing representation has not eradicated structural stressors throughout the workforce. Women urologists exhibit greater rates of adverse treatment, gender bias, and work-family conflict,¹⁷ but recent data reveal male urologists also face distinctive pressures, such as growing administrative burdens, shrinking reimbursement, and less access to industry participation.

Shared workforce challenges help remind us that equity interventions will also need to target system-level drivers, instead of solely metrics, to improve morale, retention, and institutional culture.^6,7

Academic promotion and leadership

Lasting deficiencies remain in leadership inclusion and advancement. Women take an additional 1.2 years to advance from Assistant to Associate Professor and hold only approximately 10% of leadership roles across professional societies.^18,19 On subspecialty boards, few improvements have occurred, while some board make-ups remain predominantly male.²⁰

Editorial influence mirrors these gaps, with women occupying only 11.9% of editorial board seats in major urology journals, despite growing contributions to the scholarly literature.²¹

Most importantly, our analysis identifies conflicting understandings of advancement equitability. Martin et al found considerable variance between female and male urologists on the issue of promotion transparency, with some men suggesting institutional diversity programs might have unforeseen adverse effects on equivalently qualified candidates.⁵ Although strong data is sparse, these results indicate data-based promotion thresholds are needed for assurance and cohesion across the workforce.

Authorship and scholarly visibility

Female authorship has nearly doubled over 15 years, but senior authorship is still lagging.²² Although men currently possess larger aggregate scholarly impact, Mayer et al illustrated that scholarly productivity per year is the same in both sexes, so perceived differences largely reveal preceding underrepresentation instead of scholarly output quality.²³

It is also important to recognize that editorial diversity fosters authorship equity. Journals with greater female membership on their editorial boards have been found to publish substantially high rates of female first and senior authorship;³ however, Burg et al found that women occupy only 14.6% of editorial board roles globally, demonstrating the structural barriers on visibility and influence.²⁴

Interestingly, some male authors have cited apprehensions that institutional diversity targets would impact peer review processes and authorship attributions. ⁵ Although these impressions are anecdotal, they indicate the need for transparent editorial policies for reviewer education to ensure trust in merit-based paths to publication.

Compensation and industry engagement

Gender-based compensation differences persist throughout various career stages for urologists. Contributing factors present early; Cone et al noted that women residents will expect lower starting salaries and feel less prepared for contract negotiations, thus perpetuating downstream injustices.²⁷ Such similar discrepancies also exist in industry payments.⁴

It is noteworthy that high-value industry relationships are predominantly found among a limited group of high-volume surgeons, the majority of whom are male.²⁸ This concentration may lead to perceptions of inequity, particularly if evolving institutional policies alter these opportunities without clear and transparent criteria, thereby emphasizing the necessity for equitable engagement frameworks.

Patient preferences and clinical outcomes

Patient preference greatly determines referral behavior and procedural exposure. Notably, however, clinical results are the same across surgeon sexes, with the rate of complications and mortality statistically indistinguishable. ¹⁰ Such results indicate the enhancement of patient-centered services by access and comfort without the loss of quality.

Referral behavior that is congruent with gender could potentially cause unequal access to complex cases, thus affecting female surgeons disproportionately across their training and in their academic careers, a nuance that warrants further investigation.

Emerging evidence: Perceptions of reverse bias and clinician well-being

One of the most novel contributions of this review is its synthesis of preliminary evidence on male urologists’ perceptions of reverse bias, burnout, and equity within evolving institutional frameworks.

Burnout affects all genders: rates approach 47–68% among practicing urologists, driven primarily by workload, administrative burden, and institutional culture.^6,7

On our review, one study demonstrated that some male urologists perceive reduced transparency in promotion and hiring, potentially affecting morale and career satisfaction.⁵ Another evaluated clinician well-being across 476 participants and identified high rates of burnout linked to work hours, coping behaviors, and lifestyle factors, underscoring the importance of supporting wellness early in training to promote long-term retention.³¹

These findings, although preliminary, highlight an urgent research gap. Without measurement-first approaches, equity initiatives risk unintended consequences, including workforce fragmentation, reduced engagement, and burnout across genders.

Policy implications

To achieve true equity, measurement must precede mandates. Professional societies and institutions should prioritize:

• Equity dashboards: Transparent reporting of workforce composition, leadership representation, compensation, authorship, and industry engagement

• Structured mentorship and sponsorship: Inclusive mentorship programs pairing trainees and faculty across genders, coupled with leadership and negotiation training

• Transparent promotion criteria: Clear benchmarks to ensure institutional policies are perceived as merit-based and fair

• Balanced industry engagement frameworks: Equal access to consulting and research sponsorships based on objective performance metrics

These strategies would enhance institutional trust and ensure that diversity efforts strengthen, rather than fracture, the workforce.

Future directions

This review identifies three critical research priorities:

1. Longitudinal workforce tracking: Multi-institutional registries monitoring leadership advancement, attrition, and satisfaction over time

2. Perception audits: Validated instruments measuring perceived fairness, bias, and opportunity among male and female clinicians alike

3. Equity intervention outcomes: Rigorous evaluation of mentorship, sponsorship, and policy reforms to identify which models drive diversity without unintended harms

Limitations

This review has several limitations. Because most included studies originated from U.S.-based cohorts, the generalizability of these findings to international urology settings may be limited. Most of the study designs — including surveys, bibliometric studies, and registries — are heterogeneous, making the ability to cross-compare challenging. Finally, reverse bias perception comes largely from initial, small-numbered studies, so higher-quality, multicenter data are needed. Additionally, future research should also examine how intersecting factors, such as race, age, and caregiving responsibilities, compound gender-based experiences within the urology workforce.

CONCLUSIONS

Over the past 15 years, urology has made measurable progress toward gender equity, particularly in trainee recruitment, authorship representation, and patient-centered care. The proportion of women entering urology has steadily increased, and scholarly contributions from female authors have nearly doubled. Yet, this review highlights that significant disparities persist across leadership representation, compensation, editorial influence, and access to high-complexity surgical cases.

Of note, this review identifies an emerging but previously unexplored axis: the growing awareness among male urologists of reverse bias. Although strong data are scarce, initial studies indicate that some male clinicians sense less visibility on promotion, hiring, and opportunities for industry interaction, with potential impact on morale, burnout, and retention. These findings underscore the need for balanced, evidence-informed approaches that maintain equity systems favorable to all clinicians, but also further the goals of diversity.

Attainment of sustainable equity requires a measurement-first strategy. Physician organizations, such as the AUA, CUA, and EAU, should lead the charge in the creation of equity dashboards tracking workforce composition, timing of promotion, compensation thresholds, authorship rates, and industry affiliations. Setting transparent metrics would help increase accountability, rebuild institutional trust, and ensure that dynamic policies are perceived as fair, objective, and inclusive.

Finally, there is a critical need for multi-institutional, prospective investigations designed to examine the causal determinants of inequity and determine the empirical impact of diversity initiatives. Future studies should not only address the current barriers faced by women but also explore clinician well-being, fairness perception, and attrition risk among all genders.

By aligning institutional policies with data-driven frameworks, including the SAGER guidelines, the AAMC DEI principles, and the recommendations of the CUA, the field of urology is presented with the opportunity to guide surgery towards a model characterized by transparent, balanced, and patient-centered equity. This approach not only fosters innovation but also enhances workforce cohesion and improves care for the diverse populations that we serve.